Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001178937-25-000065
Filing Date
2025-11-18
Accepted
2025-11-18 16:28:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3953
  Complete submission text file 0001178937-25-000065.txt   5690
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Subject) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40288 | Film No.: 251495134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY CAMANA BAY E9 KY1-9009
Business Address C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY CAMANA BAY E9 KY1-9009 (415) 801-4675
Logos Global Master Fund LP (Reporting) CIK: 0001831371 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144